WebIrinotecan and cisplatin versus etoposide and cisplatin in small-cell lung cancer: JCOG 9511. Clin Lung Cancer. 2000 Aug;2 (1):23-4. Web7 giu 2015 · Presently, JCOG1211 is an on-going clinical Phase II trial of segmentectomy with lymph node dissection for patients with cT1N0 lung cancer that comprises <50% GGO in Japan. The prognosis does not seem to differ after lobectomy or segmentectomy for patients with cT1bN0 lung adenocarcinoma that meets the N0 criteria including solid …
PubMed
Web但话说回来,出现局部复发的,有多少是实性结节?如果绝大多数是实性结节,ggo几乎不复发,那是否说明亚肺叶切除的适应证可以朝更大尺寸的ggo扩展?jcog1211的初步结果表明,对于3cm以内,ctr<0.5的ggo,肺段切除的5年rfs和5年os都达到了98%以上。 Web13 nov 2024 · PubMed; Scopus (6) Google Scholar, 4 ... (JCOG1211). Gen Thorac Cardiovasc Surg. 2024; 65: 267-272. Crossref; PubMed; Scopus (54) Google Scholar; Likewise, in patients with NSCLC and interstitial lung diseases, sublobar resection may decrease the occurrence of acute exacerbations. ... emily\u0027s ghost engine
A non-randomized confirmatory trial of segmentectomy for
Web25 gen 2024 · Thus, we commenced another non-randomized confirmatory trial (JCOG1211). The aim of this study is to confirm the efficacy of segmentectomy for … Web5 nov 2024 · PubMed. Google Scholar. Kazuo Nakagawa, Kazuo Nakagawa Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, ... JCOG0802, JCOG0804 and JCOG1211) . Currently, the group is running clinical trials including a phase III trial on lymph node dissection for clinical T1-3N0M0 NSCLC (JCOG1413), ... Web胸部薄切ct 所見に基づくすりガラス影優位のct1n0 肺癌に対する区域切除の非ランダム化検証的試験 (jcog1211)の詳細情報です。進捗状況,試験名,対象疾患名,実施都道府県,お問い合わせ先などの情報を提供しています。 dragon by tecky